Literature DB >> 15242408

Enforcing order within a complex locus: current perspectives on the control of V(D)J recombination at the murine T-cell receptor alpha/delta locus.

Michael S Krangel1, Juan Carabana, Iratxe Abbarategui, Ryan Schlimgen, Abbas Hawwari.   

Abstract

V(D)J recombination proceeds according to defined developmental programs at T-cell receptor (TCR) and immunoglobulin loci as a function of cell lineage and stage of differentiation. Although the molecular details are still lacking, such regulation is thought to occur at the level of accessibility of chromosomal recombination signal sequences to the recombinase. The unique and complex organization of the TCRalpha/delta locus poses intriguing regulatory challenges in this regard: embedded TCRalpha and TCRdelta gene segments rearrange at distinct stages of thymocyte development, there is a highly regulated progression of primary followed by secondary rearrangements involving Jalpha segments, and there are important developmental constraints on V gene segment usage. The locus therefore provides a fascinating laboratory in which to explore the basic mechanisms underlying developmental control. We provide here a current view of cis-acting mechanisms that enforce the TCRalpha/delta locus developmental program, and we emphasize the unresolved issues that command the attention of our and other laboratories.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242408     DOI: 10.1111/j.0105-2896.2004.00155.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  50 in total

Review 1.  Recent insights into the transcriptional control of the Tcra/Tcrd locus by distant enhancers during the development of T-lymphocytes.

Authors:  Cristina Hernández-Munain
Journal:  Transcription       Date:  2015

2.  Isolation and Ex Vivo Culture of Vδ1+CD4+γδ T Cells, an Extrathymic αβT-cell Progenitor.

Authors:  Christian Welker; Rupert Handgretinger; Karin Schilbach
Journal:  J Vis Exp       Date:  2015-12-07       Impact factor: 1.355

3.  Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency.

Authors:  Wenxia Jiang; Brian J Lee; Chen Li; Richard L Dubois; Monica Gostissa; Frederick W Alt; Shan Zha
Journal:  Blood       Date:  2015-02-26       Impact factor: 22.113

4.  Regulation of T cell receptor alpha gene assembly by a complex hierarchy of germline Jalpha promoters.

Authors:  Abbas Hawwari; Cheryl Bock; Michael S Krangel
Journal:  Nat Immunol       Date:  2005-04-03       Impact factor: 25.606

5.  Role for rearranged variable gene segments in directing secondary T cell receptor alpha recombination.

Authors:  Abbas Hawwari; Michael S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

6.  Noncoding transcription controls downstream promoters to regulate T-cell receptor alpha recombination.

Authors:  Iratxe Abarrategui; Michael S Krangel
Journal:  EMBO J       Date:  2007-09-20       Impact factor: 11.598

7.  Productive coupling of accessible Vbeta14 segments and DJbeta complexes determines the frequency of Vbeta14 rearrangement.

Authors:  Sheila Ranganath; Andrea C Carpenter; Megan Gleason; Albert C Shaw; Craig H Bassing; Frederick W Alt
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

8.  Initiation of allelic exclusion by stochastic interaction of Tcrb alleles with repressive nuclear compartments.

Authors:  Ryan J Schlimgen; Karen L Reddy; Harinder Singh; Michael S Krangel
Journal:  Nat Immunol       Date:  2008-06-08       Impact factor: 25.606

9.  Requirement for enhancer specificity in immunoglobulin heavy chain locus regulation.

Authors:  Igor I Kuzin; Ludmila Bagaeva; Faith M Young; Andrea Bottaro
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 10.  Control of early stages in invariant natural killer T-cell development.

Authors:  Taishan Hu; Idoia Gimferrer; José Alberola-Ila
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.